PRKAG2 and cardiomyopathy: Genetic testing, prompted by a family history of sudden cardiac death (SCD), using a targeted panel sequencing including sarcomere protein gene mutations and other cardiomyopathy-related genes, identified a heterozygous PRKAG2 mutation.